Skip to content

French National Observatory of Patients With Thymic Epithelial Tumor

French National Observatory of Patients With Thymic Epithelial Tumor

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02724696
Acronym
RYTHMIC
Enrollment
3262
Registered
2016-03-31
Start date
2012-01-31
Completion date
2025-12-31
Last updated
2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thymic Epithelial Tumor

Keywords

Thymic Epithelial Tumor, Cohort study, IFCT

Brief summary

RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a French nationwide network for TET with the objective of territorial coverage by regional expert centers and systematic discussion of patients management at national tumor board.

Detailed description

RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a nationwide network for TET appointed in 2012 by the French National Cancer Institute. The objectives of the network are management of clinical tumor boards and central pathologic review of all cases. RYTHMIC Tumor Board is based on initial histopathological diagnosis. RYTHMIC is a comprehensive tool for research: * to improve the management of patients * to monitor dedicated actions * to screen patients for future translational and clinical trials

Interventions

None listed

Sponsors

Intergroupe Francophone de Cancerologie Thoracique
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient with Thymic Epithelial Tumors

Exclusion criteria

* histology other than Thymic Epithelial Tumors

Design outcomes

Primary

MeasureTime frameDescription
histological type5 yearshistological type according to the WHO classification 2004/2015
Masaoka-Koga stage5 yearsMasaoka-Koga stage
ITMIG/IASLC 2014/2015 stage5 yearsITMIG/IASLC 2014/2015 stage

Secondary

MeasureTime frameDescription
Questions raised at the national expert multidisciplinary tumor board5 yearsDiagnosis/Imaging, Surgery, Chemotherapy, Radiotherapy

Countries

France

Contacts

Primary ContactFranck Morin
contact@ifct.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026